Key result
Echocardiographic strain accurately predicts left ventricular dysfunction in young cancer survivors with ~0.91 AUC.
Why the study?
Serial cardiovascular screening is recommended for childhood, adolescent and young adult cancer survivors, but optimal screening strategies, including echocardiography-based myocardial strain, are not fully defined.
Does surveillance echocardiography-based longitudinal and circumferential myocardial strain associate with fractional shortening and predict future cardiac dysfunction (FS ≤ 27%) in childhood, adolescent, and young adult cancer survivors treated with anthracyclines?
Cohort (n=189)
Image analysis performed by sonographers and cardiologist blinded to clinical outcome
No
Does surveillance echocardiography-based longitudinal and circumferential myocardial strain associate with fractional shortening and predict future cardiac dysfunction (FS ≤ 27%) in childhood, adolescent, and young adult cancer survivors treated with anthracyclines?
Answers are grounded in this paper and cite their sources.
Adding longitudinal and circumferential myocardial strain to routine echocardiographic surveillance in young cancer survivors can help identify patients at risk for subsequent left ventricular systolic dysfunction (FS ≤ 27%), particularly starting 5 years after diagnosis.
Cardiovascular disease is a leading contributor to mortality among childhood, adolescent and young adult (C-AYA) cancer survivors. While serial cardiovascular screening is recommended in this population, optimal screening strategies, including the use of echocardiography-based myocardial strain, are not fully defined. Our objective was to determine the relationship between longitudinal and circumferential strain (LS, CS) and fractional shortening (FS) among survivors. This single-center cohort study retrospectively measured LS and CS among C-AYAs treated with anthracycline/anthracenedione chemotherapy. The trajectory of LS and CS values over time were examined among two groups of survivors: those who experienced a reduction of >5 fractional shortening (FS) units from pre-treatment to the most recent echocardiogram, and those who did not. Using mixed modeling, LS and CS were used to estimate FS longitudinally. A receiver operator characteristic curve was generated to determine the ability of our model to correctly predict an FS ≤ 27%. A total of 189 survivors with a median age of 14 years at diagnosis were included. Among the two survivor groups, the trajectory of LS and CS differed approximately five years from cancer diagnosis. A statistically significant inverse relationship was demonstrated between FS and LS −0.129, p = 0.039, as well as FS and CS −0.413, p < 0.001. The area under the curve for an FS ≤ 27% was 91%. Among C-AYAs, myocardial strain measurements may improve the identification of individuals with cardiotoxicity, thereby allowing earlier intervention.
No takes yet. Share an insight, caveat, or question.
Bottinor et al. (2023) conducted a cohort in Childhood, adolescent, and young adult (C-AYA) cancer survivors treated with anthracycline/anthracenedione chemotherapy (n=189). Echocardiography-based longitudinal strain (LS) and circumferential strain (CS) surveillance vs. Survivors without a reduction of >5 fractional shortening (FS) units from pre-treatment to most recent echocardiogram was evaluated on Longitudinal fractional shortening (FS) and prediction of left ventricular dysfunction (FS ≤ 27%) (AUC 0.906 for predicting FS ≤ 27% (mixed model slope: LS -0.129, p=0.039; CS -0.413, p<0.001), 95% CI 0.850-0.962, p=<0.001). Echocardiographic longitudinal and circumferential strain inversely correlated with fractional shortening (p=0.039 and p<0.001) and predicted FS ≤27% with an AUC of 0.906 in young cancer survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: